Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 1 of 1 entries
Sorted by: Best Match Show Resources per page
FOXK2 downregulation suppresses EMT in hepatocellular carcinoma.

Open medicine (Warsaw, Poland)

Kong J, Zhang Q, Liang X, Sun W.
PMID: 33313412
Open Med (Wars). 2020 Jul 20;15(1):702-708. doi: 10.1515/med-2020-0129. eCollection 2020.

Forkhead box K2 (FOXK2) was first identified as an NFAT-like interleukin-binding factor. FOXK2 has been reported to act as either oncogene or tumor suppressor. However, functional and regulating mechanisms of FOXK2 in epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma (HCC)...

Cite
Kong J, Zhang Q, Liang X, et al. FOXK2 downregulation suppresses EMT in hepatocellular carcinoma. Open Med (Wars). 2020;15(1):702-708doi: 10.1515/med-2020-0129.
Kong, J., Zhang, Q., Liang, X., & Sun, W. (2020). FOXK2 downregulation suppresses EMT in hepatocellular carcinoma. Open medicine (Warsaw, Poland), 15(1), 702-708. https://doi.org/10.1515/med-2020-0129
Kong, Jian, et al. "FOXK2 downregulation suppresses EMT in hepatocellular carcinoma." Open medicine (Warsaw, Poland) vol. 15,1 (2020): 702-708. doi: https://doi.org/10.1515/med-2020-0129
Kong J, Zhang Q, Liang X, Sun W. FOXK2 downregulation suppresses EMT in hepatocellular carcinoma. Open Med (Wars). 2020 Jul 20;15(1):702-708. doi: 10.1515/med-2020-0129. eCollection 2020. PMID: 33313412; PMCID: PMC7706124.
Copy Download .nbib Format: NLM
Showing 1 to 1 of 1 entries